Literature DB >> 11570818

Detection of the presenilin 1 COOH-terminal fragment in the extracellular compartment: a release enhanced by apoptosis.

L Benussi1, A Alberici, M Mayhaus, U Langer, R Ghidoni, F Mazzoli, F Nicosia, L Barbiero, G Frisoni, O Zanetti, L Gasparini, R M Nitsch, G Binetti.   

Abstract

Mutations in gene encoding presenilin 1 (PS1) are responsible for the majority of familial Alzheimer's disease (FAD) cases. We studied PS1 localization in HEK293 cells and in primary neurons obtained from rat cortex and hippocampus. We first demonstrated that PS1-CTF, but neither PS1-FL nor PS1-NTF, is released into the medium as a soluble and membrane-associated form. After induction of apoptosis with staurosporine (Sts), we observed a dramatic increase in the level of PS1-CTF in the medium, both in HEK293 and in primary neurons. Immunocytochemical analysis suggested that the release of PS1-CTF might occur via membrane shedding. Abeta(1-42) treatment reduced PS1-CTF extracellular levels. This decrease was strongly associated to an impaired secretion of sAPP fragments, thus suggesting a role of PS1-CTF in the control of trafficking and generation of APP fragments. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11570818     DOI: 10.1006/excr.2001.5329

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  3 in total

Review 1.  Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer's Disease.

Authors:  Inmaculada Lopez-Font; Inmaculada Cuchillo-Ibañez; Aitana Sogorb-Esteve; María-Salud García-Ayllón; Javier Sáez-Valero
Journal:  Front Neurol       Date:  2015-06-02       Impact factor: 4.003

2.  CSF Presenilin-1 complexes are increased in Alzheimer's disease.

Authors:  María-Salud García-Ayllón; María-Letizia Campanari; Gunnar Brinkmalm; Alberto Rábano; Jordi Alom; Carlos A Saura; Niels Andreasen; Kaj Blennow; Javier Sáez-Valero
Journal:  Acta Neuropathol Commun       Date:  2013-08-06       Impact factor: 7.801

3.  Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer's disease.

Authors:  Aitana Sogorb-Esteve; María-Salud García-Ayllón; Juan Fortea; Raquel Sánchez-Valle; Alberto Lleó; José-Luis Molinuevo; Javier Sáez-Valero
Journal:  Mol Neurodegener       Date:  2016-09-29       Impact factor: 14.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.